Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-08-17

Clinical Trial Update: Effects of Dexmedetomidine on Microcirculation and Residual Kidney Function in Kidney Donors [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating the effects of dexmedetomidine on microcirculation and residual kidney function in kidney donors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Kidney Transplant, Microcirculation | Phase 4 | Status: UNKNOWN